Table 1 Clinical characteristics of the pancreatic cancer patients.

From: MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo

Variable

characteristics

n

6

Gender (male/female)

4/2

Age (yrs)

(43~67)

Histologic diagnosis

Pancreatic Ductal Adenocarcinoma

TNM staging(n)

I (2)

II (1)

III (1)

IV (2)

Back to article page